These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15056966)

  • 1. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors III. Effect of ring opening of piperazinone moiety on inhibition.
    Nishida H; Miyazaki Y; Mukaihira T; Shimada H; Suzuki K; Saitoh F; Mizuno M; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):459-62. PubMed ID: 15056966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitor.
    Nishida H; Miyazaki Y; Kitamura Y; Ohashi M; Matsusue T; Okamoto A; Hosaka Y; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1237-44. PubMed ID: 11605647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as a factor Xa inhibitor II. Substituent effect on biological activities.
    Nishida H; Miyazaki Y; Mukaihira T; Saitoh F; Fukui M; Harada K; Itoh M; Muraoka A; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1187-94. PubMed ID: 12237534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors V. A series of new derivatives containing a spiro[imidazo[1,2-a]pyrazine-2(3H),4'-piperidin]-5(1H)-one scaffold.
    Saitoh F; Mukaihira T; Nishida H; Satoh T; Okano A; Yumiya Y; Ohkouchi M; Johka R; Matsusue T; Shiromizu I; Hosaka Y; Matsumoto M; Ohnishi S
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1535-44. PubMed ID: 17077550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitors.
    Huang W; Naughton MA; Yang H; Su T; Dam S; Wong PW; Arfsten A; Edwards S; Sinha U; Hollenbach S; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):723-8. PubMed ID: 12639567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors IV. A series of new derivatives containing a spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4'-piperidin]-5-one skeleton.
    Nishida H; Mukaihira T; Saitoh F; Harada K; Fukui M; Matsusue T; Okamoto A; Hosaka Y; Matsumoto M; Shiromizu I; Ohnishi S; Mochizuki H
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):406-12. PubMed ID: 15056953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165.
    Hosaka Y; Matsumoto M; Shinozaki M; Ohno T; Yatagai Y; Kamiya M; Kurokawa M; Nishida H; Matsusue T; Mizuguchi K; Ishii H
    Eur J Pharmacol; 2006 Jan; 529(1-3):164-71. PubMed ID: 16316651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoline derivatives I: synthesis and factor Xa (FXa) inhibitory activities.
    Noguchi T; Tanaka N; Nishimata T; Goto R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Matsui Y; Fujimoto K
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):163-74. PubMed ID: 16462058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnamyl derivatives: synthesis and factor Xa (FXa) inhibitory activities.
    Noguchi T; Tanaka N; Nishimata T; Goto R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):758-70. PubMed ID: 18520077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine.
    Narendra Sharath Chandra JN; Sadashiva CT; Kavitha CV; Rangappa KS
    Bioorg Med Chem; 2006 Oct; 14(19):6621-7. PubMed ID: 16784863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinnamylindoline derivatives: synthesis and factor Xa (FXa) inhibitory activities.
    Noguchi T; Tanaka N; Nishimata T; Goto R; Hayakawa M; Sugidachi A; Ogawa T; Asai F; Fujimoto K
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1494-504. PubMed ID: 17917295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 1-arylsulfonyl-3-piperazinone derivatives as factor Xa inhibitors(1-6) VI. A series of new derivatives containing N,S- and N,SO2-spiro acetal scaffolds.
    Saitoh F; Nishida H; Mukaihira T; Kosuga N; Ohkouchi M; Matsusue T; Shiromizu I; Hosaka Y; Matsumoto M; Yamamoto I
    Chem Pharm Bull (Tokyo); 2007 Feb; 55(2):317-23. PubMed ID: 17268108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mu-opioid receptor agonists with piperazine moiety.
    Komoto T; Okada T; Sato S; Niino Y; Oka T; Sakamoto T
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1314-20. PubMed ID: 11605661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bicyclic homologues of piperazine. XI (1). Derivatives of 3,8-diazabicyclo-(3.2.1)-octane-2,4-diones with potential pharmacologic activity].
    Fontanella L; Occelli E
    Farmaco Sci; 1972 Jan; 27(1):68-78. PubMed ID: 4666526
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of some piperazine derivatives.
    Marona H; Korona R; Szneler E
    Boll Chim Farm; 2004 Nov; 143(9):329-35. PubMed ID: 15881810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and bioactivity of aripiprazole derivatives.
    Ge HX; Wang LC; Jiang ZZ; Ni SL
    Arzneimittelforschung; 2006; 56(10):673-7. PubMed ID: 17225561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of new azaphenylalanine derivatives as serine protease inhibitors.
    Obreza A; Stegnar M; Trampus-Bakija A; Prezelj A; Urleb U
    Pharmazie; 2004 Oct; 59(10):739-43. PubMed ID: 15544050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and QSAR studies on hypotensive 1-[3-(4-substituted phenylthio) propyl]-4-(substituted phenyl) piperazines.
    Saxena AK; Rao J; Chakrabarty R; Saxena M; Srimal RC
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1708-12. PubMed ID: 17234413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I.
    Peng H; Carrico D; Thai V; Blaskovich M; Bucher C; Pusateri EE; Sebti SM; Hamilton AD
    Org Biomol Chem; 2006 May; 4(9):1768-84. PubMed ID: 16633570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.